Sign in

NCT06726590Recruiting

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

The Texas Interprofessional Pharmacogenomics Registry and Repository

Source: ClinicalTrials.gov · Last updated 12 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This program collects genetic and health information to help doctors choose the right medications for patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
18 Nov 2024
Start date
Nov 2025
Primary completion date
Nov 2029
Lead sponsor
Texas A&M University
Diseases
COPD
NCT number
NCT06726590

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From Nov 2025 to the primary completion date, Nov 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning.,

Other

  • Individuals admitted to hospice.
  • Declines to participate or interact with staff/share their medical status.
  • Individuals who are unable or unwilling to provide consent.
  • Unable to verbally communicate and comprehend English language

Who the study is looking for

  • The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or
  • Individuals taking blood pressure or depression medications, even if less than five medications.
  • Ability to understand and give consent.
  • Able to consent to donate blood and/or urine samples and buccal swabs.
  • Able to answer detailed questionnaires, including quarterly questionnaires about ADRs, cognitive testing such as serial mini-mental status exams, and or quality of life questions.
  • Able to understand that their health record and changes in health status will be followed for a five-year period and shared in deidentified form with the research community.
  • All genders.
  • Any age over 18 years.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Texas A&M Family Care
Coordinator of this site? Confirm its status
BryanUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.